Fidelity Investments Variable Annuity Account I has announced an update to its summary prospectus, effective November 1, 2026. This update specifically addresses changes in current expenses for its VIP Investor Freedom Portfolios. The modification aims to provide clearer information to investors regarding the costs associated with their investments.
This change is particularly significant as it reflects Fidelity's commitment to transparency and customer service in the investment sector. By updating the prospectus, Fidelity ensures that investors have access to the most current and relevant information, allowing them to make informed decisions regarding their financial futures.
Background
Fidelity Investments Variable Annuity Account I, a part of Fidelity Investments, is an investment entity based in Boston, Massachusetts. The company operates under the Central Index Key (CIK) number 0000821051. It focuses on providing variable annuity products to its clients, which are designed to offer both investment growth and retirement income. The company has filed several recent forms, including the 497VPU on October 30, 2026, and others earlier in the year.
What the Filing Says
The filing states, "Effective November 1, 2026, current expenses for the Fidelity VIP Investor Freedom Portfolios have changed." It also notes that all references to a Fidelity mutual fund account have been removed, indicating a shift in how investors can fund their purchase payments.
Impact
This update may affect current and potential investors in Fidelity's variable annuity products, particularly those utilizing the VIP Investor Freedom Portfolios. By clarifying expense structures, Fidelity aims to enhance investor confidence and satisfaction.
What's Next
The filing does not say what happens next.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






